Open AccessPossibilities of applying a combination of targeted molecular therapies and immunotherapy in NSCLC patients
Author(s) -
Magdalena WójcikSuperczyńska,
Tomasz Jankowski,
Paweł Krawczyk
Publication year - 2022
Publication title -
nowotwory
Language(s) - English
Resource type - Journals
eISSN - 2300-2115
pISSN - 0029-540X
DOI - 10.5603/njo.a2022.0012
Subject(s) - ros1 , medicine , immunotherapy , lung cancer , combination therapy , oncology , targeted therapy , nivolumab , kinase , cancer research , cancer , adenocarcinoma , biology , microbiology and biotechnology